GSK fast-tracks cancer drug that may add billions in annual sales
- Postato il 12 aprile 2026
- Di The Times
- 0 Visualizzazioni
GSK fast-tracks cancer drug that may add billions in annual sales
The FTSE 100 pharma company’s Mo-Rez gynaecological drug is a ‘key asset’ and a potential blockbuster that showed strong results in trials